Results 241 to 250 of about 28,214,434 (299)

Nurse-led hospital violence intervention programme versus standard care in Wales: a cost-effectiveness analysis. [PDF]

EClinicalMedicine
Premji S, Moore SC, Tod D, Hamilton M, Bandyopadhyay A, Shepherd J, Yeomans H, Battaglia A, O'Reilly D, Walker SM.   +9 more
europepmc   +1 more source

Economic evaluation of Hirschsprung disease testing strategies for children with medically-refractory chronic constipation: A cost-effectiveness analysis. [PDF]

J Pediatr Surg
Obidike PC, Wanchek TN, Rialon KL, King A, Cheng LS.   +4 more
europepmc   +1 more source

Cost-effectiveness analysis of finotonlimab in the treatment of advanced recurrent metastatic head and neck squamous cell carcinoma in China. [PDF]

Hum Vaccin Immunother
Gao Y, Lv N, Diao R.
europepmc   +1 more source

Cost-effectiveness analysis of Enfortumab vedotin and pembrolizumab for advanced urothelial carcinoma. [PDF]

Medicine (Baltimore)
Cheng H, Li J, Mao N.
europepmc   +1 more source

Cost-Effectiveness Analysis of Patient Self-Management of Warfarin Among Patients With Non-Valvular Atrial Fibrillation. [PDF]

Pharmacotherapy
Kategeaw W, Witt DM, King JB, Malone DC, Chaiyakunapruk N.   +4 more
europepmc   +1 more source

Long-Acting PrEP for People With High Vulnerability to HIV Acquisition in Brazil: A Cost-Effectiveness Analysis. [PDF]

J Int AIDS Soc
Chen W, Luz PM, Srinivasan A, Grinsztejn B, Scott JA, Neilan AM, Veloso VG, Dugdale CM, Freedberg KA.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cost-Effectiveness Analysis 2.0

New England Journal of Medicine, 2017
As prominent groups in U.S. health care ramp up use of cost-effectiveness analysis to measure and communicate the value of new drugs and other interventions, an expert panel has released updated guidelines for such analysis.
Peter J Neumann, Gillian D Sanders
exaly   +3 more sources